Kane Biotech conducts cutting edge research and development through our on-site CL2 biofilm research laboratory. Our research includes early stage identification, prototyping, screening of anti biofilm activity, formulation and product development, product claim validation, QC testing, post market research and branding. We use multiple quantitative and qualitative assays for biofilm testing including the Minimum Bioreactor Eradication Concentration (MBEC™) assay.

Our capabilities include, but are not limited to:

• Biofilm antimicrobial testing
• Planktonic antimicrobial testing
• Aerobic and anaerobic microorganisms as well as bacterial spores

We also have a GMP certified manufacturing facility on site.